[1]
P. Skalij, P. Tokajuk, S. Jelski, and M. Z. Wojtukiewicz, “Long-term disease control during TAS-102 therapy in the VI line treatment in a 73-year-old mCRC patient. A case report”, OncoReview, vol. 10, no. 1(37), pp. 15-17, Mar. 2020.